Binding of propranolol and chlorpromazine by mitochondrial membranes.
D010129:4-Aminobenzoic Acid / Q000494:pharmacology; D000588:Amines / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D002118:Calcium / Q000494:pharmacology; D002746:Chlorpromazine / Q000378:metabolism*; D003408:Cresols / Q000494:pharmacology; D003864:Depression, Chemical; D066298:In Vitro Techniques; D008566:Membranes / Q000378:metabolism; D008930:Mitochondria, Liver / Q000378:metabolism*; D009281:Naphthalenes / Q000494:pharmacology; D010743:Phospholipids / Q000502:physiology; D011108:Polymers / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D011398:Promethazine / Q000494:pharmacology; D011433:Propranolol / Q000378:metabolism*; D051381:Rats; D013096:Spermine / Q000494:pharmacology; D013268:Stimulation, Chemical; D013347:Subcellular Fractions / Q000378:metabolism*; D013451:Sulfonic Acids / Q000494:pharmacology
D000588:Amines; D003408:Cresols; D009281:Naphthalenes; D010743:Phospholipids; D011108:Polymers; D013451:Sulfonic Acids; D013096:Spermine; D011433:Propranolol; D011398:Promethazine; D011188:Potassium; D002118:Calcium; D010129:4-Aminobenzoic Acid; D002746:Chlorpromazine